Ivelin Georgiev

Displaying 1 - 4 of 4

Grant set to support Georgiev’s research to identify new antibodies

Vanderbilt University Medical Center’s Ivelin Georgiev, PhD, has received a three-year, $750,000 award from The G. Harold and Leila Y. Mathers Foundation of Rye Brook, New York, to support research aimed at rapidly identifying potent, disease-fighting antibodies.

Related Categories: 
antibodies Ivelin Georgiev pathology microbiology and immunology The G. Harold and Leila Y. Mathers Foundation Vanderbilt Program in Computational Microbiology and Immunology

“Ultra-potent” antibody against COVID-19 variants isolated at VUMC

“Ultra-potent” antibody against COVID-19 variants isolated at VUMC

Related Categories: 
Research antibodies cell reports coronavirus COVID variant COVID-19 Ivelin Georgiev monoclonal antibodies pathology microbiology and immunology Vanderbilt Vaccine Center

New tool may speed antibody, vaccine research

New tool may speed antibody, vaccine research

Related Categories: 
Research antibody therapies computer science Ivelin Georgiev LIBRA-seq pathology microbiology and immunology School of Engineering vaccine development Vanderbilt Vaccine Center

A “public” target for HIV

Individuals produce unique sets of antibodies in response to HIV infection. That diversity — and the ability of the human immunodeficiency virus to rapidly change its protein coat to avoid detection — has stymied efforts to develop an anti-HIV vaccine.

Related Categories: 
Health and Medicine Gates Foundation HIV HIV/AIDS Ivelin Georgiev NCATS NHLBI NIAID NIGMS NIH pathology microbiology and immunology Vaccine Vanderbilt Vaccine Center